Venmax Drugs and Pharmaceuticals Ltd Allots Equity Shares Following Warrant Conversion
Venmax Drugs and Pharmaceuticals Ltd announced the allotment of 28,00,000 equity shares on March 23, 2026, following the exercise of convertible warrants. The allotment was approved by the Board of Directors at a meeting held on the same day.Jugal Kishore Bhagat and Pushpa Bhaju, both non-promoters, exercised their right to convert warrants. Jugal Kishore Bhagat converted 13,00,000 warrants, and Pushpa Bhaju converted 15,00,000 warrants. The equity shares were allotted at an issue price of Rs. 20 each, with a face value of Rs. 10 per share.
The company received Rs. 4,20,00,000 from the warrant holders for the conversion.
Following the allotment, Venmax Drugs and Pharmaceuticals Ltd's paid-up capital has increased to Rs. 11,58,29,300, comprising 1,15,82,930 equity shares.
Table: Allotment Details
| Name of Allottees | Category | No. of warrants held | No. of warrants applied for conversion | No. of Equity Shares allotted |
|---|---|---|---|---|
| Jugal Kishore Bhagat | Non-Promoter | 13,00,000 | 13,00,000 | 13,00,000 |
| Pushpa Bhaju | Non-Promoter | 15,00,000 | 15,00,000 | 15,00,000 |
| Total | Total | 28,00,000 | 28,00,000 | 28,00,000 |
Table: Post-Issue Shareholding
| Name of Allottees | Pre Issue Holding | Post Issue Holding |
|---|---|---|
| Jugal Kishore Bhagat | - | 13,00,000 |
| Pushpa Bhaju | - | 15,00,000 |
| Total | Total | 28,00,000 |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.